SAT-199 - All-Oral Treatment with Daclatasvir Plus Sofosbuvir ± Ribavirin in HCV Genotype 3-Infected Patients with Advanced Fibrosis or Cirrhosis: An Analysis of Ally-3 and Ally-3+
| Autor: | Kowdley, K., Angus, P., Bernstein, D., Bronowicki, J.-P., Leroy, V., Pockros, P., Bhore, R., Rana, K., Jimenez-Exposito, M.J. |
|---|---|
| Zdroj: | In Journal of Hepatology 2016 64(2) Supplement:S789-S790 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect